Edgewise Therapeutics
EWTX
EWTX
95 hedge funds and large institutions have $539M invested in Edgewise Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more capital invested
Capital invested by funds: $443M → $539M (+$95.7M)
12% more funds holding
Funds holding: 85 → 95 (+10)
4.77% more ownership
Funds ownership: 105.05% → 109.82% (+4.8%)
Holders
95
Holding in Top 10
2
Calls
$124K
Puts
$47K
Top Buyers
| 1 | +$8.01M | |
| 2 | +$7.75M | |
| 3 | +$5.52M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.04M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.7M |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$2.47M | |
| 3 | -$1.66M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.46M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$724K |